Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-21

Clinical Trial Update: Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain [NA]

View source ↗

Summary

This clinical trial is recruiting to define how TRPV4 in Schwann cells may contribute to pain in oral squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: New York University | Conditions: Oral Cancer, Squamous Cell Carcinoma | NA | Status: RECRUITING